BDBM100794 US8507533, 300::US8507533, 97::US8507533, 98

SMILES OC(=O)CCNC(=O)c1ccc(cc1)C(Nc1ccc(nc1)-n1cnc(c1)C(F)(F)F)C1CCCC1

InChI Key InChIKey=KZWVSKJOXJGUQM-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 100794   

TargetPro-glucagon(Human)
Pfizer

US Patent
LigandPNGBDBM100794(US8507533, 300 | US8507533, 98 | US8507533, 97)
Affinity DataKi:  93nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Pfizer

US Patent
LigandPNGBDBM100794(US8507533, 300 | US8507533, 98 | US8507533, 97)
Affinity DataKi:  1.10E+3nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent